GeneTex

  • Country / Location Selection

United States (US)

VANGL2 blocking peptide

Cat. No. GTX48550-PEP

Species

 Human
Package
100 μg ($239)

APPLICATION

Product Note

The peptide was used in the production of GTX48550.

PROPERTIES

Form

Lyophilized powder

Buffer

Reconstitute with 200μl distilled water to obtain a 0.5mg/ml peptide solution. Lyophilized from 5% (v/v) acetonitrile/H₂O.

Preservative

No preservative

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Region/Sequence

C-QKYLRTTKQQPYH

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Vangl Planar Cell Polarity Protein 2 , Lpp1 , Ltap , Stb1 , Stbm , Stbm1 , Vangl2

Background

The protein encoded by this gene is a membrane protein involved in the regulation of planar cell polarity, especially in the stereociliary bundles of the cochlea. The encoded protein transmits directional signals to individual cells or groups of cells in epithelial sheets. This protein is also involved in the development of the neural plate. [provided by RefSeq, Sep 2011]

Research Area

REFERENCE

There are currently no references for VANGL2 blocking peptide (GTX48550-PEP). Be the first to share your publications with this product.
Submit a Reference

REVIEW

There are currently no reviews for VANGL2 blocking peptide (GTX48550-PEP). Be the first to share your experience with this product.
Submit a Review
Package List Price ($)
$ 239